Innate Pharma S.A. | |
Stock Exchange | Other OTC |
EPS |
$0.04 |
Market Cap |
$421.93 M |
Shares Outstanding |
57.46 M |
Public Float |
- |
Innate Pharma S.A. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
57.46 M |
Public Float |
- |
Innate Pharma S.A. | |
Stock Exchange | Euronext Paris |
EPS |
EUR0.05 |
Market Cap |
EUR373.91 M |
Shares Outstanding |
64.04 M |
Public Float |
43.05 M |
Address |
117, Avenue de Luminy Marseille Provence-Alpes-Cote-dAzur 13009 France |
Employees | - |
Website | http://www.innate-pharma.com/en |
Updated | 07/08/2019 |
Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. |